The potential predictive value of circulating immune cell ratio and tumor marker in atezolizumab treated advanced non-small cell lung cancer patients

Cancer Biomarkers : Section a of Disease Markers
Minglei ZhuoJun Zhao

Abstract

The PD-L1 antibody atezolizumab has shown promising efficacy in patients with advanced non-small cell lung cancer. But the predictive marker of clinical benefit has not been identified. This study aimed to search for potential predictive factors in circulating blood of patients receiving atezolizumab. Ten patients diagnosed with advanced non-small cell lung cancer were enrolled in this open-label observing study. Circulating immune cells and plasma tumor markers were examined in peripheral blood from these patients before and after atezolizumab treatment respectively. Relation between changes in circulating factors and anti-tumor efficacy were analyzed. Blood routine test showed that atezolizumab therapy induced slightly elevation of white blood cells count generally. The lymphocyte ratio was increased slightly in disease controlled patients but decreased prominently in disease progressed patients in response to atezolizumab therapy. Flow cytometric analysis revealed changes in percentage of various immune cell types, including CD4+ T cell, CD8+ T cell, myeloid-derived suppressor cell, regulatory T cell and PD-1 expressing T cell after atezolizumab. Levels of plasma tumor marker CEA, CA125 and CA199 were also altered after anti...Continue Reading

References

Nov 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·T OkazakiT Honjo
Jan 17, 2003·The New England Journal of Medicine·Lin ZhangGeorge Coukos
Mar 19, 2005·Nature Reviews. Immunology·C M Hawrylowicz, A O'Garra
Dec 24, 2005·The New England Journal of Medicine·Franck PagèsJérôme Galon
May 20, 2008·Human Immunology·Sytse J PiersmaSjoerd H van der Burg
Aug 13, 2008·Expert Opinion on Biological Therapy·Marij J P WeltersSjoerd H van der Burg
Apr 24, 2010·Cancer Immunology, Immunotherapy : CII·Suzanne Ostrand-Rosenberg
Nov 2, 2011·Gynecologic Oncology·Wei-Ting HwangGeorge Coukos
Jan 13, 2012·Current Opinion in Immunology·Suzanne L TopalianDrew M Pardoll
Oct 9, 2012·Cancer·Robert Ferris
Feb 2, 2013·Nature Reviews. Drug Discovery·Sheng YaoLieping Chen
Mar 20, 2013·Frontiers in Oncology·Yana G Najjar, James H Finke
Jun 2, 2015·The New England Journal of Medicine·Dung T LeLuis A Diaz
Jun 2, 2015·The New England Journal of Medicine·Julie BrahmerDavid R Spigel
Sep 29, 2015·The New England Journal of Medicine·Hossein BorghaeiJulie R Brahmer
Dec 25, 2015·Trends in Immunology·Davalyn R Powell, Anna Huttenlocher
Apr 9, 2016·Oncoimmunology·Sumanta K Pal, Marcin Kortylewski
Nov 1, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Benjamin WeideJedd D Wolchok
Nov 10, 2016·Vaccines·Viktor UmanskyJochen Utikal
Mar 14, 2017·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Stephen J BagleyCorey J Langer
Apr 12, 2017·Nature·Alexander C HuangE John Wherry
Nov 25, 2017·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Junko TanizakiKazuhiko Nakagawa

❮ Previous
Next ❯

Citations

Nov 22, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M OlivaL L Siu
Aug 15, 2020·Frontiers in Immunology·Elisa PeranzoniIlaria Marigo
Jun 3, 2021·International Journal of Molecular Sciences·Teresa MagnesThomas Melchardt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.